Compound, process for the preparation of it, pharmaceutical formulation, use of the compound, processes to inhibit gastric acid secretion, for the treatment of inflammatory gastrointestinal diseases, and for the treatment or prophylaxis of conditions involving helicobacter pylori infection of the mucosa human gastric, and, pharmaceutical formulations for use in inhibiting gastric acid secretion, for use in the treatment of inflammatory gastrointestinal diseases, and for use in the treatment or prophylaxis of conditions involving helicobacter pylori infection of the human gastric mucosa

摘要

"COMPOUND, PROCESS FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL FORMULATION, USE OF THE COMPOUND, PROCESSES TO INHIBIT THE GASTRIC ACID SECRETATION, FOR THE TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISEASES, AND FOR THE TREATMENT OF HOSPITAL DEVELOPMENT AND DEVELOPMENT OF HOSPITAL DEVELOPMENT HUMAN GASTRIC MUCOSA, AND PHARMACEUTICAL FORMULATIONS FOR USE IN THE INHIBITION OF GASTRIC ACID SECRETION, FOR USE IN THE TREATMENT OF GASTROINTESTINAL INFLAMMATORY DISEASES, AND FOR THE USE IN THE TREATMENT OR HYPOTHESICAL HYDRAULIC HYDRAULIC CONDITIONS OF EMERGENCY AND UNDERSTANDING. ". The present invention concerns new compounds and their therapeutically acceptable salts of formula (I), which inhibit the exogenous or endogenously stimulated secretion of gastric acid and in this way can be used in the prevention and treatment of inflammatory gastrointestinal diseases.